Insulet Corp. logo
PODDInsulet Corp.

Average EV/Sales Ratio

EV/Sales Ratio

The today ev/sales ratio is 3.76x as of Thursday, June 25, 2026, shown against its trailing averages.

PODD EV/Sales Ratio

PODD Average EV/Sales Ratio

PODD EV/Sales Ratio Averages

EV/SALES RATIO TODAY

3.76x

EV/SALES RATIO TTM

7.76x

EV/SALES RATIO 3Y

8.94x

EV/SALES RATIO 5Y

12.19x

EV/SALES RATIO 10Y

12.39x

EV/SALES RATIO 15Y

10.55x

EV/SALES RATIO 20Y

10.23x

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy